SAT-087 MALIGNANT HYPERTENSION IN IGA NEPHROPATHY WITH THROMBOTIC MICROANGIOPATHY
K. Mannai, H. Gaied, M. Jerbi, R. Aoudia, E. Abderrahim, Rim Goucha, T. Ben Abdallah
Abstract
K. Mannai, H. Gaied, M. Jerbi, R. Aoudia, E. Abderrahim, Rim Goucha, T. Ben Abdallah
Abstract
Malignant hypertension (MHT) concerns 7 to 15% of IgA nephropathy (IgAN) patients. In some studies, a significant association of MHT with microangiopathy in IgAN has been reported. Herein, we describe the prevalence and characteristics of MHT in primitive IgAN patients with thrombotic microangiopathy (TMA).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Malignant hypertension (MHT) concerns 7 to 15% of IgA nephropathy (IgAN) patients. In some studies, a significant association of MHT with microangiopathy in IgAN has been reported. Herein, we describe the prevalence and characteristics of MHT in primitive IgAN patients with thrombotic microangiopathy (TMA).
Key concepts: Thrombotic microangiopathy, Medicine, Nephropathy, Microangiopathy, Internal medicine, Gastroenterology, Endocrinology, Diabetes mellitus